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Resting cells of Kluyveromyces marxianus were used in the bioreduction of ethyl 4,4,4-triﬂuoro-3-oxobut-
anoate and ethyl 4,4,4-trichloro-3-oxobutanoate with 81% and 4% yields and 29% and 73% enantiomeric
excess, respectively. The differences observed were attributed to the tri-halide structures.
 2013 Published by Elsevier Ltd.Introduction
Kluyveromyces marxianus has gained attention over the past
years because of its high potential of industrial application.1–5 This
yeast has speciﬁc features that make it a good choice for industrial
process including a very fast growth rate, thermotolerance, and the
ability to grow on a variety of carbon sources.4,6,7 Many of the re-
searches are focused on its capacity of utilizing lactose,3,5,8 while
its ability as catalysts has not been extensively investigated.1
Microbial catalysis of organic substrates presents great catalytic
power and exceptional chemo-, regio-, and stereoselectivity.1,9,10
The interest in this catalysis is bigger in the pharmaceutical indus-
try due to the demand for obtaining drug intermediates with spe-
ciﬁc stereochemistry. It can be more easy and cheaper to obtain an
enantiopure drug by use of pre-prepared chiral molecules, than an
enantiomeric puriﬁcation of a racemic compound.2,11
The enantiopure ethyl 4,4,4-triﬂuoro- and 4,4,4-trichloro-3-
hydroxybutanoate are highly desirable chiral starting materials
for the synthesis of compounds of synthetic or pharmaceutical
interest. The ﬂuorinated b-hydroxy esters may be used in industry
as building blocks for the synthesis of optically active ﬂuoro-organ-
ic compounds with increased pharmacological proﬁles.12–15 The
ethyl 4,4,4-trichloro-3-hydroxybutanoate is a key intermediate inElsevier Ltd.the synthesis of (S)-malic acid, a source to numerous important
compounds.16
Some synthetic approaches for obtaining optically pure b-hy-
droxy ester compounds from their corresponding b-keto esters in-
volve both the chemical and the microbial asymmetric reduction.
Chemical asymmetric synthesis is generally more aggressive,
requiring the use of high temperatures and of metallic complexes
of ruthenium (Ru-BINAP) as catalysts.13,17,18 Besides, the generated
product is less convenient to the production of drugs because of
the presence of undesirable chiral organometallic complexes.19
On the other hand, microbial reduction takes place in a limited
number of stages in mild conditions and is more speciﬁc. Other
advantages are lower costs, ample availability of potential micro-
bial strains for biocatalysis, and little environmental impact. These
advantages justify the increasing use of biocatalysts in asymmetric
reductions.12,19,20
K. marxianus has been shown as a viable option for the asym-
metric reduction of b-keto esters.2,21,22 It is also worthy to note
that its high growth rate permits to obtain big amounts of biomass
to the biocatalytic process with low costs. This yeast, as many, has
different reductases and dehydrogenases, usually NADPH and
NADH dependent.6,23 Due to the presence of these enzymes that
can be active over the same substrates, the stereoselectivity can
be low.6,12,23 The costs for the isolation of the enzymes together
with the need of regeneration of the coenzymes make the use of
resting cells more favorable.24 It is important to study the behavior
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understand how the different enzymes act and further use the
information to the synthesis of enantiomeric pure building blocks.
As part of a research study on the inﬂuence of the structure of
the substrate in the bioreduction, we report here the yeast K.
marxianus in the reduction of ethyl 4,4,4-triﬂuoro-3-oxobutanoate
(1) and ethyl 4,4,4-trichloro-3-oxobutanoate (2) to obtain the cor-
responding b-hydroxy esters (3 and 4).
Results and discussion
Kluyveromyces marxianus was kindly provided by the Departa-
mento de Engenharia Bioquímica of Escola de Química at the Uni-
versidade Federal do Rio de Janeiro—Brazil. An abundant and rapid
growth of K. marxianus was observed, reiterating the potential of
the use of that microorganism in the studied bioreduction. The
reduction reactions were performed in the presence of glucose to
permit the regeneration of the coenzymes by the resting cells.
To obtain the biomass, K. marxianus preserved in Sabouraud
Dextrose Agar was grown at 30 C and 150 rpm for 48 h in Erlen-
meyer ﬂasks (250 mL) containing 50 mL of medium with the fol-
lowing composition (g/L): glucose, 10; yeast extract, 5;
(NH4)2SO4, 1; MgSO47H2O, 1; peptone, 5 and pH 6.5 (sterilized
by autoclaving at 121 C for 15 min). The grown cells were har-
vested by centrifugation at 3500 rpm for 10 min, washed twice
with distilled water, and added at the concentration of 5 g/L (dried
weight) to 50 mL of reduction medium containing (g/L): glucose,
50; MgCl2, 1. After 30 min, 0.25% (v/v) of the appropriate substrate
(ethyl 4,4,4-triﬂuoro-3-oxobutanoate: 17 mM; ethyl 4,4,4-tri-
chloro-3-oxobutanoate: 15 mM) in ethanol was added to the
medium.
The experiments were performed under agitation (150 rpm) at
30 C for 24 h, in triplicate. After incubation time cells were har-
vested by centrifugation and the supernatant was extracted with
ethyl acetate, then the organic phase was dried over anhydrous
MgSO4, ﬁltered, and concentrated under vacuum.
The yeast was able to catalyze the bioreduction of both triha-
lides (1 and 2) toward the (S)-()-enantiomer, but under the same
conditions led to very distinct yield and enantiomeric excess. The
ethyl 4,4,4-triﬂuoro-3-hydroxybutanoate (3) was obtained with
good yield (81%) and an ee of 29%. Unlike, the ethyl 4,4,4-tri-
chloro-3-hydroxybutanoate (4) was obtained with a high enantio-
meric excess (73%), but a low yield (4%) (Scheme 1).Hydroxy ester Y (%) ee (%) Configuration 
S 
S 
R O
OO R O
OOH
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Scheme 1. Bioreduction of ethyl 4,4,4-trihalide-3-oxobutanoateby K. marxianus(1
and 2) to correspondent ethyl 4,4,4-triﬂuoro-3-hydroxybutanoate (3) or ethyl4,4,4-
trichloro-3-hydroxybutanoate (4).The racemic b-hydroxy esters (3 and 4) obtained by NaBH4
reduction25 were used to ﬁnd the suitable conditions for chiral
GC analysis. The reduction of the carbonyl group was identiﬁed
from the observed infrared spectra (IR), 1H NMR spectra, and gas
chromatography of the b-hydroxy esters.
The IR spectra were recorded on a Perkin–Elmer 1420 spec-
trometer in potassium bromide pellets. The IR spectrum of the
compound (3) shows well deﬁned signals in the 3438 cm1 (C–
OH) and 1732 cm1 (C@O) that corresponds to hydroxyl and ester
carbonyl moiety, respectively. However, two signals can be seen
clearly in the carbonyl group area (1738 and 1766 cm1) beyond
the 3407 cm1 (C–OH) of the compound (4) IR spectrum. The signal
at 1766 cm1 refers to the ketone group and is indicative of low
conversion. The 1H NMR spectra were recorded using a Moran Ul-
tra (Oxford Instruments) at 300 MHz spectrophotometer for solu-
tions in CDCl3.
The enantiomeric excess (ee) of the products was determined
by optical rotation. The optical rotation was measured by ACATEC
PDA 9300 polarimeter from CHCl3 solutions at the sodium D line
(589 nm) operating at 27 C. Both trihalide compounds show ee
of the (S)-isomer (3a and 4a).12,16,26,27
The chiral compounds analyses were performed using a Hew-
lett–Packard (HP)-5890 gas chromatograph (CGAR-chiral).28 The
b-keto ester 1 and correspondent products 3a and 3b were ob-
served at 1.8, 2.2, and 2.1 min, respectively. The b-keto ester 2
and correspondent products 4a and 4b were observed at 10.9,
16.3, and 16.4 min, respectively. The chromatograms obtained
can be seen in Figures 1 and 2.Figure 1. Chiral GC analysis on column BGB-176 (25 m  0.25 mm  0.25 lm), at
120 C: (A) ethyl 4,4,4-triﬂuoro-3-oxobutanoate (substrate); (B) ethyl (R)-4,4,4-
triﬂuoro-3-hydroxybutanoate (Aldrich); (C) ethyl 4,4,4-triﬂuoro-3-hydroxybutano-
ate (racemate obtained via NaBH4 reduction); (D) Kluyveromyces marxianus
reduction. Retention times (tR): tR (substrate) = 1.8 min, tR ((S)-enantio-
mer) = 2.19 min, tR ((R)-enantiomer) = 2.0 min.
Figure 2. Chiral GC analysis on column Lipodex E (25 m  0.25 mm), at 170 C: (A)
ethyl 4,4,4-trichloro-3-oxobutanoate (substrate); (B) ethyl 4,4,4-trichloro-3-
hydroxybutanoate (racemate obtained via NaBH4 reduction); (C) Kluyveromyces
marxianus reduction. Retention times (tR): tR (substrate) = 10.9 min, tR ((S)-enan-
tiomer) = 16.2 min, tR ((R)-enantiomer) = 16.4 min.
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used Saccharomyces cerevisiae, usually in the form of baker’s yeast,
or its isolated enzymes are the most common ones due to the easy
access to this microorganism.12,16,19,29 Baker’s yeast reduces ethyl
4,4,4-triﬂuoro-3-oxobutanoate (1) to the corresponding (R)-b-hy-
droxy ester with up to 100% yield.12,30 It is possible to obtain the
(S)-isomer using baker’s yeast, but it is necessary to add a (R)-
reductase inhibitor, such as allyl alcohol.12,30
Quite the contrary, K. marxianus used in our work was able to
reduce ethyl 4,4,4-triﬂuoro-3-oxobutanoate (1) to the correspond-
ing (S)-b-hydroxy ester (3a, yield: 81%; ee: 29%) without addition
of inhibitors, a selectivity which is rare among whole cells. Another
microorganism described to catalyze the reduction of 1 to (S)-iso-
mer (3a) was Klebsiella pneumoniae.11 However, it is important to
note that this bacterium is of dubious safety and is not recom-
mended for industrial use, while K. marxianus is considered as a
safe microorganism.31
Despite the yield obtained with K. marxianuswas comparable to
that obtained with baker’s yeast, the ee was lower (29%). The ste-Figure 3. Comparison of LUMO orbital coefﬁcients of b-keto esters 1, 2, and 5. The LUM
deepest blue (low electron density).reoselectivity differences are primarily related to the activity of
more than one enzyme present in the yeast cells.6,23 At least four
alcohol desidrogenases are present in K. marxianus6 that could ex-
hibit different catalytic activities over the b-keto esters. The use of
reductase inhibitors has been reported to increase the ee.12,30 The
same approach can be probably used to increase the ee of (S)-iso-
mer obtained by using K. marxinaus reduction of ethyl 4,4,4-tri-
ﬂuoro-3-oxobutanoate (1).
The reduction of ethyl 4,4,4-trichloro-3-oxobutanoate (2) has
been less studied than (1). The literature reports the production
of (S)-isomer (4a) by use of baker’s yeast or fresh carrot root cells
with yield and ee around 50% and 85%, respectively.16,32 In our
work, the use of K. marxianus provided a good ee (73%) but a low
yield (4%) of (S)-isomer (4a).
The enzymes that act on 1 with a yield of 81% were not able to
reduce 2with a reasonable yield. These results suggest that the dif-
ferences observed may be related to the structure of the molecule,
as also noted by ChA et al. in their work.23
In order to gain some insight into the inﬂuence of the substrate
structure in the bioreduction with K. marxianus, we analyzed the
three-dimensional frontier orbital coefﬁcient contribution from
the b-keto ester (1 and 2) and ethyl-3-oxobutanoate (5). The ethyl
(R)-3-hydroxybutanoate (97% yield and 67% ee) had been obtained
from compound 5 by bioreduction with the same strain of K.marxi-
anus.21 The computations were performed using SPARTAN´10

(Wavefunction Inc., Irvine, CA, 2000).
The density of lowest-unoccupied molecular (LUMO) maps re-
vealed the most disabled of electrons in the molecule that are more
likely to suffer attack by nucleophiles. Thus, these maps are able to
demonstrate the differences in the direction of nucleophilic attacks
between similar molecular systems.33
It was possible to observe that the keto groups of 1 and 5 are
more electrophilic, showing that they have a greater tendency to
react with nucleophiles (strong blue) on LUMO orbital map, which
explains the high yield. However, compound 2 has not shown a
strong blue region and consistent low yield (Fig. 3).
These data suggest that the sharp difference in yield between
the b-keto ester (1) and (2) may have been related to the fact that
the CF3 group in 1 promotes greater electropositivity to the keto
group than the CCl3 group in 2. And also, the steric effects caused
by the large volume of CCl3 group linked to carbon in the b position
of the keto ester, probably also account for the lack of reactivity of
2.
Conclusions
Considering the increasing attention that Kluyveromyces marxi-
anus has gained these past years and its potential to stereoselective
reduction of carbonyl compounds, it is important to study the
behavior of the whole cells of K. marxianus on different substratesO’s orbital density coefﬁcient mapped from deepest red (high electron density) to
3070 S. S. S. Oliveira et al. / Tetrahedron Letters 54 (2013) 3067–3070to try to understand how the different enzymes act. This yeast like
fungus showed abundant growth and easy manipulation and is
being used with good results in the bioreduction of b-keto esters.
In the present work ethyl 4,4,4-triﬂuoro- oxobutanoate and ethyl
4,4,4-trichloro-3-oxobutanoate were bioreduced to the respective
(S)-hydroxy esters using a wild strain of K. marxianus. In a molec-
ular investigation of the results obtained, the LUMO maps suggest
that the differences obtained in the reduction of the trihalides (1
and 2) were most probably due to their structure differences.
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